Inflammation cellular platform (INCEPLAT) for testing anti-inflammatory compounds for SARS-CoV-2
Blanca D. López‐Ayllón, Laura Mendoza‐García, Ana de Lucas‐Rius…·María Montoya
The paper develops a cellular platform using SARS-CoV-2 ORF-expressing A549 cells to screen anti-inflammatory compounds from Fasciola hepatica, showing FhNEJ extract reduces IL11 levels.